JAMA Neurology : Clinical Effectiveness of Direct Oral Anticoagulants vs Warfarin in Older Patients With Atrial Fibrillation and Ischemic Stroke
Interview with Adrian F. Hernandez, MD, MHS, author of Clinical Effectiveness of Direct Oral Anticoagulants vs Warfarin in Older Patients With Atrial Fibrillation and Ischemic Stroke: Findings From the Patient-Centered Research Into Outcomes Stroke Patients Prefer and Effectiveness Research (PROSPER) Study (Source: JAMA Specialty Journals Author Interviews)
Source: JAMA Specialty Journals Author Interviews - July 22, 2019 Category: General Medicine Source Type: podcasts

PodMed – Week of October 2, 2017
This week’s topics include aspirin discontinuation risks, HIV in those 50 and older, big data and chronic lung disease, and genetic testing and warfarin use. Program notes: 0:34 Genetic testing and warfarin dosing 1:35 Looked at genetics to determine 2:33 Other agents for blood thinning 3:01 Use of big data and chronic lung disease 4:01 […] (Source: Johns Hopkins Medicine Weekly Health News)
Source: Johns Hopkins Medicine Weekly Health News - September 29, 2017 Category: Consumer Health News Authors: Elizabeth Tracey Johns Hopkins Medicine Tags: All Podcasts Chronic Disease Genetics Geriatrics Heart And Vascular HIV PodMed Sexually Transmitted Infections (STI) Source Type: podcasts

Genotype-guided warfarin dosing after arthroplasty, oxygen for stroke, delirium diagnosis and treatment, and more
Editor's Summary by Edward H. Livingston, MD, Deputy Editor of JAMA, the Journal of the American Medical Association, for the September 26, 2017 issue (Source: JAMA: This Week's Audio Commentary)
Source: JAMA: This Week's Audio Commentary - September 26, 2017 Category: General Medicine Authors: JAMA, the Journal of the American Medical Association, and The JAMA Network Source Type: podcasts

Apr 7 Cardiology News
Cost effects of risk-factor management in AF, apixaban costs vs warfarin, bioresorbable-scaffold woes, exercise as heart-failure therapy, and surgical left atrial appendage closure are discussed. (Source: Medscape Cardiology Podcast)
Source: Medscape Cardiology Podcast - April 7, 2017 Category: Cardiology Authors: Medscape Source Type: podcasts

Assessing Stroke Risk in Adult Congenital Heart Disease
Drs Lyle, Ammash, and McLeod discuss risk stratification for stroke in adults with complex congenital heart disease and how to choose between warfarin or the direct oral anticoagulants in the absence of data. (Source: Medscape Cardiology Podcast)
Source: Medscape Cardiology Podcast - March 27, 2017 Category: Cardiology Authors: Medscape Source Type: podcasts

Jan 6 Cardiology News
Surgical AF ablation, warfarin discontinuation, patient understanding of tests, geographic variation of care, and familial hypercholesterolemia are reviewed in this week's podcast. (Source: Medscape Cardiology Podcast)
Source: Medscape Cardiology Podcast - January 6, 2017 Category: Cardiology Authors: Medscape Source Type: podcasts

Aug 19 Cardiology News
PCSK9 drug pricing, medical adherence, warfarin stability, hs-troponin, brain protection during TAVR, and an FDA decision on a factor Xa antidote are discussed by Dr Mandrola in this week's podcast. (Source: Medscape Cardiology Podcast)
Source: Medscape Cardiology Podcast - August 19, 2016 Category: Cardiology Authors: Medscape Source Type: podcasts

Arefa MD's Morning Report: Statin-SSRI Combination, Statins in CKD, Warfarin, Exercise
Dr Arefa Cassoobhoy provides a quick rundown of this week's news on statins to augment SSRIs, statins in CKD, warfarin and INR stability, and exercise as prevention. (Source: Medscape Medscape Podcast)
Source: Medscape Medscape Podcast - August 19, 2016 Category: Journals (General) Authors: Medscape Source Type: podcasts

Jun 24 Cardiology News
Insulin-Statin-PCSK9 linkage, QOL on warfarin, ticagrelor adherence, cardio-protection for Breast CA Rx, Brugada Syndrome and AF ablation as a placebo are discussed by Dr Mandrola in this week's podcast. (Source: Medscape Cardiology Podcast)
Source: Medscape Cardiology Podcast - June 24, 2016 Category: Cardiology Authors: Medscape Source Type: podcasts

Apr 29 Cardiology News
ECG screening in athletes, warfarin for AF, sugar-sweetened beverages, CT-induced cancer treatment costs, and night-shift work are the topics discussed by John Mandrola in this week ’ s podcast. (Source: Medscape Cardiology Podcast)
Source: Medscape Cardiology Podcast - April 29, 2016 Category: Cardiology Authors: Medscape Source Type: podcasts

NOACs Cut Bleeding vs Warfarin Following Acute VTE
Dr Goldhaber reviews a meta-analysis he coauthored of RE-COVER trial data suggesting that new oral anticoagulants may be a better option than warfarin for treating acute VTE. (Source: Medscape Cardiology Podcast)
Source: Medscape Cardiology Podcast - February 4, 2016 Category: Cardiology Authors: Medscape Source Type: podcasts

NOACs Cut Bleeding vs Warfarin Following Acute VTE
Dr Goldhaber reviews a meta-analysis he coauthored of RE-COVER trial data suggesting that new oral anticoagulants may be a better option than warfarin for treating acute VTE. (Source: Medscape Critical Care Podcast)
Source: Medscape Critical Care Podcast - February 4, 2016 Category: Intensive Care Authors: Medscape Source Type: podcasts

Aug 21 Cardiology News
Early use of NOACs or warfarin, ICD generator change, obesity, social determinants of health, ABIM, and valsartan/sacubitril are the topics discussed by Dr John Mandrola. (Source: Medscape Cardiology Podcast)
Source: Medscape Cardiology Podcast - August 21, 2015 Category: Cardiology Authors: Medscape Source Type: podcasts

Dabigatran vs Warfarin; Acute Venous Thromboembolism
A Pooled Analysis of RE-COVER™ and RE-COVER™ II (Abstract 594). Dr. Sam Schulman discussed his abstract titled Influence of Age and Renal Function on Efficacy and Safety of Dabigatran Versus Warfarin... Author: feeds Added: 04/15/2015 (Source: Oncology Tube)
Source: Oncology Tube - April 15, 2015 Category: Cancer & Oncology Source Type: podcasts

NOAC Bleeding Lower In Meta-analysis
Dr Goldhaber reviews a meta-analysis showing lower rates of bleeding for new oral anticoagulants vs warfarin. (Source: Medscape Cardiology Podcast)
Source: Medscape Cardiology Podcast - January 7, 2015 Category: Cardiology Authors: Medscape Source Type: podcasts

Warfarin Time in the Therapeutic Range: Room for Improvement
Dr Samuel Goldhaber reviews a study of nationwide management of warfarin for stroke prevention in atrial fibrillation, showing poor real-world TTRs. (Source: Medscape Cardiology Podcast)
Source: Medscape Cardiology Podcast - December 31, 2014 Category: Cardiology Authors: Medscape Source Type: podcasts

Warfarin in AF Patients on Dialysis: Worst of Both Worlds
Samuel Goldhaber describes the shocking findings of a study of warfarin use for AF prevention in patients on hemodialysis. (Source: Medscape Cardiology Podcast)
Source: Medscape Cardiology Podcast - December 10, 2014 Category: Cardiology Authors: Medscape Source Type: podcasts

Warfarin in AF Patients on Dialysis: Worst of Both Worlds
Samuel Goldhaber describes the shocking findings of a study of warfarin use for AF prevention in patients on hemodialysis. (Source: Medscape Nephrology Podcast)
Source: Medscape Nephrology Podcast - December 10, 2014 Category: Urology & Nephrology Authors: Medscape Source Type: podcasts

Manesh R. Patel, MD - Assessing the Difference Between Warfarin and the Novel Oral Anticoagulants
Assessing the Difference Between Warfarin and the Novel Oral Anticoagulants (Source: PeerView CME/CE Audio Podcast - Primary Care)
Source: PeerView CME/CE Audio Podcast - Primary Care - October 10, 2014 Category: Primary Care Authors: PVI, PeerView Institute for Medical Education Tags: Science, Medicine Source Type: podcasts

Increased Stroke Risk Caused by Warfarin?
An increase in stroke risk supports the theory of a transient hypercoagulable state at the start of warfarin treatment in patients with atrial fibrillation. (Source: Medscape Neurology Podcast)
Source: Medscape Neurology Podcast - September 19, 2014 Category: Neurology Authors: Medscape Source Type: podcasts

Genotype-Guided Drug Therapy in Cardiology
From clopidogrel to warfarin and statins, genotyping can affect drug metabolism but should genetics guide pharmacotherapy? Drs. Harrington, Ohman, Mega, and Robinson have a spirited discussion. (Source: Medscape Cardiology Podcast)
Source: Medscape Cardiology Podcast - March 6, 2014 Category: Cardiology Authors: Medscape Source Type: podcasts

JAMA 2014-03-04, Vol. 311, No. 9, Author Audio Interview
Interview with Juan Jesús Carrero, PhD(Pharm and Med), author of Warfarin, Kidney Dysfunction, and Outcomes Following Acute Myocardial Infarction in Patients With Atrial Fibrillation (Source: JAMA Author Interviews)
Source: JAMA Author Interviews - March 4, 2014 Category: Journals (General) Authors: The JAMA Network Source Type: podcasts

Warfarin, Kidney Dysfunction, and Outcomes Following Acute Myocardial Infarction in Patients With Atrial Fibrillation
Interview with Juan Jesús Carrero, PhD(Pharm and Med), author of Warfarin, Kidney Dysfunction, and Outcomes Following Acute Myocardial Infarction in Patients With Atrial Fibrillation (Source: JAMA Author Interviews)
Source: JAMA Author Interviews - March 4, 2014 Category: Journals (General) Authors: The JAMA Network Source Type: podcasts

Warfarin for afib patients with CKD, housing mobility in childhood and adolescent mental health, review of management of tremor, and more.
Editor's Audio Summary by Jody W. Zylke, MD, Senior Editor, the Journal of the American Medical Association, for the March 05, 2014 issue (Source: JAMA: This Week's Audio Commentary)
Source: JAMA: This Week's Audio Commentary - March 4, 2014 Category: General Medicine Authors: JAMA, the Journal of the American Medical Association, and The JAMA Network Source Type: podcasts

Novel Anticoagulants vs Warfarin: Latest Analyses
For patients with atrial fibrillation, 4 novel anticoagulants appear to be slightly more effective and safer than warfarin for preventing ischemic stroke. (Source: Medscape Pharmacists Podcast)
Source: Medscape Pharmacists Podcast - January 30, 2014 Category: Drugs & Pharmacology Authors: Medscape Source Type: podcasts

Warfarin Reversal: Time for a Change?
A recent study compares frozen plasma with prothrombin complex concentrate for warfarin reversal. (Source: Medscape Internal Medicine Podcast)
Source: Medscape Internal Medicine Podcast - January 23, 2014 Category: Internal Medicine Authors: Medscape Source Type: podcasts

Warfarin Reversal: Time for a Change?
A recent study compares frozen plasma with prothrombin complex concentrate for warfarin reversal. (Source: Medscape Pharmacists Podcast)
Source: Medscape Pharmacists Podcast - January 23, 2014 Category: Drugs & Pharmacology Authors: Medscape Source Type: podcasts

Pharmacogenomic Warfarin Dosing: Worth the Cost?
Three new studies look at whether genotype-guided dosing of vitamin K antagonists leads to more precise dosing. (Source: Medscape Pharmacists Podcast)
Source: Medscape Pharmacists Podcast - December 23, 2013 Category: Drugs & Pharmacology Authors: Medscape Source Type: podcasts

COAG and EU-PACT: The Pharmacogenetics of Warfarin Dosing
Dr Pereira reviews the conflicting results of COAG and EU-PACT and assesses the utility of pharmacogenetic dosing of warfarin. (Source: Medscape Pharmacists Podcast)
Source: Medscape Pharmacists Podcast - December 5, 2013 Category: Drugs & Pharmacology Authors: Medscape Source Type: podcasts

Rapid Warfarin Reversal With 4-Factor Prothrombin
Clinical experience suggests that recently approved 4-factor prothrombin complex concentrate is superior to fresh frozen plasma in the management of warfarin-associated hemorrhage. (Source: Medscape Critical Care Podcast)
Source: Medscape Critical Care Podcast - November 7, 2013 Category: Intensive Care Authors: Medscape Source Type: podcasts

Is It Time to Stop Using Warfarin for DVT?
Does rivaroxaban for treatment of deep venous thrombosis (DVT) warrant changing our current treatment with vitamin K antagonists (VKAs)? Dr. Orman examines the evidence. (Source: Emergency Medicine News: SoundsBites: Q&A)
Source: Emergency Medicine News: SoundsBites: Q&A - September 5, 2013 Category: Emergency Medicine Source Type: podcasts

New echo study raises questions; aspirin often added to warfarin in AF without CAD, despite bleeding risk; two types of pulmonary hypertension respond to novel agent; diovan data-manipulation scandal in Japan
(Source: Radio TheHeart.org)
Source: Radio TheHeart.org - July 29, 2013 Category: Cardiology Authors: theheart.org Tags: This week in cardiology from heartwire Source Type: podcasts

New echo study raises questions; aspirin often added to warfarin in AF without CAD, despite bleeding risk; two types of pulmonary hypertension respond to novel agent; Diovan data-manipulation scandal in Japan
New echo study raises questions; aspirin often added to warfarin in AF without CAD, despite bleeding risk; two types of pulmonary hypertension respond to novel agent; diovan data-manipulation scandal in Japan (Source: Radio TheHeart.org)
Source: Radio TheHeart.org - July 29, 2013 Category: Cardiology Authors: theheart.org Tags: This week in cardiology from heartwire Source Type: podcasts

#182: ACC 2013: Stopping rivaroxaban and warfarin temporarily in AF patients yields similar risks; PREVAIL yanked from ACC program; Watchman device meets safety end point; Niacin full results in HPS2-THRIVE; Another strike for digoxin in AF
ACC 2013: Stopping rivaroxaban and warfarin temporarily in AF patients yields similar risks; PREVAIL yanked from ACC program; Watchman device meets safety end point; Niacin full results in HPS2-THRIVE; Another strike for digoxin in AF (Source: Radio TheHeart.org)
Source: Radio TheHeart.org - March 14, 2013 Category: Cardiology Authors: theheart.org Tags: This week in cardiology from heartwire Source Type: podcasts

#181: What's going to be hot at ACC 2013; rivaroxaban STEMI study hits print as FDA delivers setback; Watchman ups quality of life vs chronic warfarin in nonvalvular AF; FDA again seeks more info on rivaroxaban in ACS
What's going to be hot at ACC 2013; rivaroxaban STEMI study hits print as FDA delivers setback; Watchman ups quality of life vs chronic warfarin in nonvalvular AF; FDA again seeks more info on rivaroxaban in ACS (Source: Radio TheHeart.org)
Source: Radio TheHeart.org - March 7, 2013 Category: Cardiology Authors: theheart.org Tags: This week in cardiology from heartwire Source Type: podcasts

Bleeding Risk in Afib? Don't Fear Warfarin
This F1000 commentary reports on a study whose findings support the use of antithrombotic therapy in treating patients with atrial fibrillation. (Source: Medscape Pharmacists Podcast)
Source: Medscape Pharmacists Podcast - February 1, 2013 Category: Drugs & Pharmacology Authors: Medscape Source Type: podcasts

#170: SCAI releases new consensus on "ad hoc" PCI; societies prepare interventionalists for new payment codes; heart-healthy diet additive to drug benefits in secondary prevention; increased mortality with digoxin in AF; warfarin for six months should be
SCAI releases new consensus on "ad hoc" PCI; societies prepare interventionalists for new payment codes; heart-healthy diet additive to drug benefits in secondary prevention; increased mortality with digoxin in AF; warfarin for six months should be (Source: Radio TheHeart.org)
Source: Radio TheHeart.org - December 14, 2012 Category: Cardiology Authors: theheart.org Tags: This week in cardiology from heartwire Source Type: podcasts

#169: Pall cast on Durata ICD lead as FDA document made public; "holistic" analysis shows domino effect of TAVI risk factors; CT coronary angiography identifies significant plaques in "normal" arteries; major bleeds with warfarin in AF are often fatal;
Pall cast on Durata ICD lead as FDA document made public; "holistic" analysis shows domino effect of TAVI risk factors; CT coronary angiography identifies significant plaques in "normal" arteries; major bleeds with warfarin in AF are often fatal; low seru (Source: Radio TheHeart.org)
Source: Radio TheHeart.org - November 30, 2012 Category: Cardiology Authors: theheart.org Tags: This week in cardiology from heartwire Source Type: podcasts

#162: Beta blockers of no use in stable CAD; docs debate valve choice; Montreal cardiologist suspended; adherence to warfarin-adjustment algorithm sharpens anticoagulation: RE-LY; CV risk prediction: CRP, fibrinogen add modestly
Beta blockers of no use in stable CAD; docs debate valve choice; Montreal cardiologist suspended; adherence to warfarin-adjustment algorithm sharpens anticoagulation: RE-LY; CV risk prediction: CRP, fibrinogen add modestly (Source: Radio TheHeart.org)
Source: Radio TheHeart.org - October 12, 2012 Category: Cardiology Authors: theheart.org Tags: This week in cardiology from heartwire Source Type: podcasts

#10: Novel anticoagulants in AF: An overview of the latest data with Dr Robert McBane
The past year has brought an embarrassment of riches in the realm of anticoagulation for patients with atrial fibrillation, as dabigatran, rivaroxaban, and apixaban vie to compete with warfarin. (Source: Radio TheHeart.org)
Source: Radio TheHeart.org - July 11, 2012 Category: Cardiology Authors: theheart.org Tags: Mayo Clinic Talks Source Type: podcasts